BioCentury
ARTICLE | Company News

DynaGen, Remel LP deal

November 13, 1995 8:00 AM UTC

Privately held Remel (Lenexa, Kan.) received exclusive rights to manufacture and sell DYGN's MycoAKT latex agglutination products in the U.S., and semi-exclusive rights for the rest of the world. The ...